PROCEPT BioRobotics Corporation

PROCEPT BioRobotics is a medical device company specializing in robotic-assisted, ultrasound-guided treatment for benign prostatic hyperplasia (BPH) and men's health conditions. The company manufactures Aquablation therapy systems, a waterjet-based robotic platform for prostate tissue resection that preserves continence and sexual function. The flagship product is the HYDROS Robotic System, described as a next-generation, AI-powered platform for Aquablation therapy. The system uses computer-assisted treatment planning to enable precision tissue resection while maximizing preservation of important anatomical structures across prostates of all shapes and sizes. Aquablation therapy has demonstrated clinical efficacy for safe, effective, and durable symptom relief in published urological literature. The company serves urology departments and specialized surgical centers in the United States, supporting surgeons in performing minimally invasive BPH treatment. Products are designed for hospital operating rooms and urology surgical suites.